Early and intermediate-term results of the extracardiac conduit total cavopulmonary connection for functional single-ventricle hearts

Abstract

The clinical results of EC-TCPC in patients with functional single ventricle were satisfactory. The patients who needed fenestration during operation had higher risk of surgical mortality. Significant atrioventricular valve regurgitation had negative impact on intermediate survival.

Comparable long‐term results of the extracardiac conduit total cavopulmonary connection in heterotaxy to non‐heterotaxy patients

“…After Fontan‐type palliation, progressive deterioration of atrioventricular valve regurgitation with further systemic ventricular dysfunction was noted especially in heterotaxy patients. Unfortunately, in our previous experience, reoperation for either valve repair or replacement showed suboptimal results 11 . Again, in the present study, three patients underwent reoperation for significant atrioventricular valve regurgitation during follow‐up resulted in one mortality and one heart transplantation.…”

“…Among them, lateral tunnel Fontan and extracardiac conduit (EC) total cavopulmonary connection (TCPC) have been reported with notable results 8–10 . Our previous report showed heterotaxy syndrome is not a risk factor for surgical mortality of EC TCPC in complex single ventricle population 11 . This retrospective study was designed to investigate whether the adoption of the EC TCPC in patients with heterotaxy syndrome made the early and long‐term results comparable to those of the non‐heterotaxy patients.…”

Analysis of Soil Heavy Metal Hg Pollution Source Based on GeoDetector

“…Hg is one of the most toxic pollutants. High concentration of Hg will cause ecological damage [9]. Gaseous Hg pollutants have the characteristics of moving with the atmosphere.…”

Deconstructing the Tissue Engineered Vascular Graft: Evaluating Scaffold Pre-Wetting, Conditioned Media Incubation, and Determining the Optimal Mononuclear Cell Source

“…1–5 In addition, these conduits fail to grow with the child, often requiring serial operations to revise or upsize the graft, which each increase the risk of morbidity and mortality. 6 The development of a tissue engineered vascular graft (TEVG) holds great promise for pediatric patients born with congenital cardiac anomalies.…”

“…Surgical palliation of congenital heart disease often necessitates the use of Gore-Tex or Dacron vascular grafts, which are prone to infection, thrombosis, and stenosis. − In addition, these conduits fail to grow with the child, often requiring serial operations to revise or upsize the graft, which each increase the risk of morbidity and mortality . The development of a tissue engineered vascular graft (TEVG) holds great promise for pediatric patients born with congenital cardiac anomalies .…”